Company / Profit Margin
CHAMPIONS ONCOLOGY, INC. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-14.5%
FY2025
5-year range
-14.5% / 8.3%
FY2021-FY2025
Trend
-275.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -276% YoY in FY2025, a notable deviation from the 9-year average annual change of -6%.
Based on SEC 10-K filings.
-14.5% in FY2025 with a 5-year CAGR of -15.4%.
Declined from 1.1% to -14.5% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -15.4pp
- 5-Year Change
- -15.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 275.7% year-over-year.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14.5% | -275.7% |
| FY2024 | 8.3% | +637.5% |
| FY2023 | 1.1% | +27.3% |
| FY2022 | 0.9% | +113.5% |
| FY2021 | -6.5% | -840.9% |
| FY2020 | 0.9% | +113.5% |
| FY2019 | -6.5% | +85.4% |
| FY2018 | -44.7% | +52.2% |
| FY2017 | -93.4% | +37.0% |
| FY2016 | -148.3% | -131.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026